|
2016 |
Discovery of Stable Non-opioid Dynorphin A Analogues Interacting at the Bradykinin Receptors for the Treatment of Neuropathic Pain. |
Frank Porreca, PhD |
|
2016 |
17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion. |
John M. Streicher, PhD |
|
2016 |
Triad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Dynorphin A analogs for the treatment of chronic neuropathic pain. |
|
|
2016 |
Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery. |
Jeffrey J. Lochhead, PhD |
|
2016 |
Effect of Reproductive History and Exogenous Hormone Use on Cognitive Function in Mid- and Late Life. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
Cyclic non-opioid dynorphin A analogues for the bradykinin receptors. |
Frank Porreca, PhD |
|
2016 |
Structure-Activity Relationships of [des-Arg(7)]Dynorphin A Analogues at the κ Opioid Receptor. |
Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, John M. Streicher, PhD, Todd Vanderah, PhD |
|
2016 |
Altered brain energetics induces mitochondrial fission arrest in Alzheimer's Disease. |
Roberta Diaz Brinton, Ph.D |
|
2016 |
(S)-Lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. |
Frank Porreca, PhD, Todd Vanderah, PhD |
|
2016 |
Cyclic Opioid Peptides. |
|
|
2016 |
Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Modification of amphipathic non-opioid dynorphin A analogues for rat brain bradykinin receptors. |
Frank Porreca, PhD |
|
2015 |
Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities. |
Roberta Diaz Brinton, Ph.D |
|
2015 |
Orthopedic surgery and bone fracture pain are both significantly attenuated by sustained blockade of nerve growth factor. |
Patrick W Mantyh |
|
2015 |
Use of Animal Models in Understanding Cancer-induced Bone Pain. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
|
2015 |
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states. |
Frank Porreca, PhD, Todd Vanderah, PhD |
|
2015 |
My Obstetrician Got Me Fired: How Work Notes Can Harm Pregnant Patients and What to Do About It. |
Sigrid Gardner Williams |
|
2015 |
Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif. |
John M. Streicher, PhD |
|
2015 |
White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2015 |
Design, synthesis, and biological evaluation of a series of bifunctional ligands of opioids/SSRIs. |
|
|
2015 |
Perimenopause as a neurological transition state. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
|
2015 |
Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism. |
Patrick W Mantyh |
|
2015 |
Temperature differentially facilitates spontaneous but not evoked glutamate release from cranial visceral primary afferents. |
Tally Largent-Milnes, PhD |
